GGrantIndex
← Leaderboards

Carolinas Medical Center

Charlotte, NC

Compare ↔
$53,985,465
Total funding
44
Grants

Funding over time

peak $5.4M · FY2005–24
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$45,169,758 · 36
AHRQ$6,173,597 · 6
CDC$2,642,110 · 2

By mechanism

R01$23,201,303 · 18
U01$18,051,339 · 3
R18$4,776,607 · 3
R21$2,837,274 · 8
UH3$1,179,698 · 1
K01$1,043,739 · 1

Investigators at Carolinas Medical Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Hazel Tapp$3,428,6761 gr2Stephanie P Taylor$3,152,6424 gr3Marc Kowalkowski$2,208,1673 gr4Anthony J Weekes$1,013,1241 gr5Andrew D McWilliams$142,4931 gr

All-Time

Most funded here, all years

1Peter B Lockhart$5,651,0625 gr2Michael F Dulin$5,599,5814 gr3Hazel Tapp$3,428,6761 gr4Stephanie P Taylor$3,152,6424 gr5Alan E Jones$3,056,6721 gr6Marc Kowalkowski$2,208,1673 gr7Serguei Y Semenov$1,854,9442 gr8Dimitrios Stefanidis$1,571,7262 gr

Largest grants

Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN$2,937,087
R18 · FY2010 · HS
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (ORARAD)$2,079,075
U01 · FY2018 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients$1,817,765
U01 · FY2014 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients$1,736,990
U01 · FY2015 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients$1,674,848
U01 · FY2013 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients (ORARAD)$1,618,120
U01 · FY2019 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients$1,454,033
U01 · FY2016 · DE
Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad$1,409,114
U01 · FY2022 · DE
Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients$1,397,240
U01 · FY2012 · DE
Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRad$1,242,008
U01 · FY2021 · DE
Randomized Trial of non-Surgical Therapy and Oral Hygiene Instruction to Reduce Risk of Infective Endocarditis$1,179,697
UH3 · FY2023 · DE
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1,013,015
U01 · FY2013 · NS
Antisense therapy for DMD-Optimization and toxicology of AON for exon 45 skipping$1,013,015
U01 · FY2013 · NS
Oral Hygiene, Periodontal Disease, and Infective Endocarditis$796,423
R01 · FY2015 · DE
Oral Hygiene, Periodontal Disease, and Infective Endocarditis$793,575
R01 · FY2016 · DE
Oral Hygiene, Periodontal Disease, and Infective Endocarditis$793,575
R01 · FY2017 · DE
Oral Hygiene, Periodontal Disease, and Infective Endocarditis$766,304
R01 · FY2014 · DE
Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care$749,122
R01 · FY2019 · CE
Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care$746,821
R01 · FY2018 · CE
Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care$746,769
R01 · FY2020 · CE